Morgan Stanley Discloses Passive Stake in Cryoport (CYRX)
Ticker: CYRX · Form: SC 13G · Filed: Feb 8, 2024 · CIK: 1124524
| Field | Detail |
|---|---|
| Company | Cryoport, Inc. (CYRX) |
| Form Type | SC 13G |
| Filed Date | Feb 8, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**Morgan Stanley just revealed a new passive stake in Cryoport (CYRX).**
AI Summary
Morgan Stanley, a major financial institution, filed an initial SC 13G on February 8, 2024, disclosing its ownership of Cryoport, Inc. common stock as of December 31, 2023. This filing indicates that Morgan Stanley holds a significant, but passive, stake in Cryoport, Inc., a company specializing in pharmaceutical preparations. For investors, this matters because it signals that a large, sophisticated investor sees value in Cryoport, potentially lending credibility to the stock.
Why It Matters
This filing shows that a major institutional investor, Morgan Stanley, has taken a position in Cryoport, Inc., which can be seen as a vote of confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This is a passive filing by an institutional investor, indicating a standard investment rather than an activist position or a significant change in company control.
Analyst Insight
An investor might view Morgan Stanley's passive stake as a positive signal, suggesting institutional confidence in Cryoport. However, without details on the size of the stake, it's difficult to gauge the full impact. Further research into Cryoport's fundamentals and Morgan Stanley's investment thesis would be prudent.
Key Players & Entities
- Morgan Stanley (company) — filer of the SC 13G, institutional investor
- Cryoport, Inc. (company) — subject company whose stock is being reported
- December 31, 2023 (date) — date of the event requiring the filing
- February 8, 2024 (date) — date the SC 13G was filed
Forward-Looking Statements
- Morgan Stanley will maintain its passive stake in Cryoport, Inc. for the foreseeable future. (Morgan Stanley) — medium confidence, target: Q4 2024
FAQ
What type of filing is this document?
This document is an initial SC 13G filing, as indicated by the 'FORM TYPE: SC 13G' and 'Amendment No.' on the cover page, signifying it's not an amendment to a previous filing.
Who is the subject company of this filing?
The subject company is Cryoport, Inc., identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cryoport, Inc.' in the filing.
Who filed this SC 13G?
This SC 13G was filed by Morgan Stanley, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MORGAN STANLEY'.
What was the date of the event that triggered this filing?
The date of the event which required this filing was December 31, 2023, as specified on the cover page: 'Date Of Event which Requires Filing of this Statement: December 31, 2023'.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), indicated by the '[x] Rule 13d-1(b)' checkbox on the cover page.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on February 8, 2024 regarding Cryoport, Inc. (CYRX).